Moxetumomab pasudotox-tdfk Intravenous and Sumatriptan and naproxen
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Sumatriptan and naproxen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: naproxen / sumatriptan
Brand name: Treximet
Synonyms: Sumatriptan and Naproxen
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Sumatriptan injection
- Moxetumomab pasudotox-tdfk Intravenous-Sumatriptan Nasal Powder
- Moxetumomab pasudotox-tdfk Intravenous-Sumatriptan Nasal Spray
- Moxetumomab pasudotox-tdfk Intravenous-Sumatriptan Nasal, Oral, Subcutaneous
- Moxetumomab pasudotox-tdfk Intravenous-Sumatriptan oral/nasal
- Moxetumomab pasudotox-tdfk Intravenous-Sumatriptan Subcutaneous
- Sumatriptan and naproxen-Moxifloxacin
- Sumatriptan and naproxen-Moxifloxacin (Systemic)
- Sumatriptan and naproxen-Moxifloxacin Hydrochloride
- Sumatriptan and naproxen-Moxifloxacin Injection
- Sumatriptan and naproxen-Moxifloxacin Intravenous
- Sumatriptan and naproxen-Moxifloxacin Tablets